SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as its community rallies around the project's consistent grind and recent milestones, fueled by a strong belief in its potential within the meme coin space on the Solana network. The community is actively discussing the coin's path to number one trending and eagerly anticipating upcoming utility releases, solidifying their conviction in Brokecoin's long-term prospects. With a focus on community engagement and transparency, Brokecoin aims to differentiate itself in the crowded altcoin market.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crowd is excited about Crow With Knife ($CAW.X), a meme token, with community members highlighting its fully circulated supply, active community, and multichain functionality across $SOL.X, BSC, $CRO.X, and $ETH.X. There is also discussion around its deflationary burn mechanism and partnerships.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as the community discusses its potential inclusion in the S&P 500, with the official announcement expected soon; the addition could lead to increased visibility and investment, though some investors are wary of a potential "sell the news" event. Community members are also weighing in on the platform's user experience, active trader focus, and comparison to competitors, while others are still referencing the company's involvement in the 2020 GME situation. Upcoming catalysts such as the Robinhood summit next week and anticipated Fed rate cuts are adding to the speculative buzz.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is trending due to its inclusion in the S&P 500, generating significant after-hours buzz and speculation about its future performance. While some community members are celebrating potential gains, others caution about overvaluation and potential insider selling. The inclusion has sparked discussions about the 'index effect' and its impact on the stock's trajectory.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors assess its potential amid the AI-driven automation landscape, with discussions focusing on its growth prospects and recent analyst ratings. Community members are debating whether the company is undervalued, citing its strong market position and partnerships, while others express concern over insider selling and the stock's historical performance. Speculation about a potential buyout is also circulating, adding to the heightened interest in PATH.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is trending following news of an expanded collaboration with United Therapeutics to develop a second inhaled therapy, sparking enthusiasm for increased revenue potential and a strengthened partnership. The community is buzzing about the implications of this new molecule and potential future catalysts, while analysts are pointing to the expansion into pulmonary and orphan diseases as a sign of growth. Some investors speculate about a possible buyout, given the deepening relationship with United Therapeutics.

WorldFinancial

WorldFinancial (WLFI.X) is trending as the community debates its purpose and potential, particularly following a large transfer of tokens to HTX and subsequent blacklisting of Justin Sun. Some investors express concerns about a potential rug pull, while others remain optimistic due to upcoming collaborations and announcements. Discussions also revolve around the token's connection to the Trump family and its role in the broader crypto and blockchain landscape, including stablecoin adoption and potential use in DeFi.

Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.

Katapult Holdings Inc

KPLT is trending due to a potential turnaround and positive Q4 performance update, with gross originations growing double-digits year-over-year. Community members are discussing the low market cap relative to revenue and comparing it to other players in the BNPL space like SEZL, with some expressing optimism for a significant price increase. Some investors are also excited about the potential for a short squeeze, and a renewed credit facility.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic ($MOS) is trending due to a mix of factors including recent Q2 earnings miss and revenue shortfalls, primarily driven by falling phosphate volumes, sparking concerns among investors. Despite improved margins, community discussions revolve around the impact of phosphate drag and potential long-term value. Analysts are weighing in with updated ratings and price targets, contributing to the stock's volatility and heightened discussion.

Didi Global, Inc. engages in the operation of mobility platforms that provides ride hailing and other related services. It operates through the following segments: China Mobility, International, and Other Initiative. The China Mobility segment consists of ride hailing, taxi hailing, chauffeur and hitch services. The International segment includes ride hailing and food delivery services in international markets, outside of China. The Other Initiatives segment mainly consists of bike and e-bike sharing, certain auto solutions, intra-city freight, community group buying, autonomous driving, and financial services. The company was founded by Wei Cheng, Qing Liu, Bo Zhang and Rui Wu on January 11, 2013 and is headquartered Beijing, China.

DiDi Global Inc - ADR

DiDi Global is surging following analyst coverage from Goldman Sachs, sparking community excitement about a potential relisting and future robotaxi ventures. Investors are closely watching for a confirmed IPO date, anticipating significant gains, while also weighing the impact of ongoing regulatory factors in China. Community members are also tracking the company's partnerships and expansion into new markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These five biotech stocks, all belonging to nano-, small- or mid-cap categories, notched the highest jump in Stocktwits message volume in the week ended Feb. 14, 2025:GlycoMimetics Inc. (+550% jump in chatter)GlycoMimetics, a late-stage biotech firm developing glycobiology-based cancer therapies, saw a surge in retail interest after a minor amendment to its merger agreement with Crescent Biopharma. The update refined the financing structure but kept intact the exchange ratio and ownership split. Once the deal closes, Crescent security holders, including new investors, will own about 96.9% of the combined company. Shares are up roughly 16% year-to-date (YTD).GRAIL Inc. (+500% jump in chatter)Cancer detection firm GRAIL made waves after announcing a partnership with Quest Diagnostics (DGX) to distribute its Galleri multi-cancer early detection test. Analysts at Guggenheim viewed the move as a major step toward broader accessibility. The stock has soared over 208% YTD.ADMA Biologics Inc. (+400% jump in chatter)ADMA Biologics, a biopharma company focused on plasma-derived therapies, saw rising buzz ahead of its upcoming fourth-quarter (Q4) earnings. Last month, it issued a preliminary report projecting full-year 2024 revenue between $417 million and $425 million, with total cash holdings exceeding $100 million. Despite the strong forecast, shares remain down more than 8% YTD.Moleculin Biotech Inc. (+295% jump in chatter)Moleculin Biotech gained traction after the FDA provided guidance on its Phase 3 trial for Annamycin, a next-generation anthracycline designed to treat relapsed/refractory acute myeloid leukemia (AML) and soft tissue sarcoma lung metastases. With an adjusted trial size, the company expects its first unblinding in late 2025 and another in early 2026. Shares have climbed over 25% YTD.Exelixis Inc. (+200% jump in chatter)Exelixis, an oncology-focused biotech, saw a surge in discussions after reporting Q4 earnings that topped estimates, prompting analysts to raise their price targets. Citi highlighted continued strength in its Cabometyx franchise and pointed to Zanza as a potential blockbuster drug. Shares are up 4.35% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

Equity

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.


Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders...

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation at...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders...

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders...

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of GlycoMimetics, Inc. (NasdaqGM: GLYC) and...

Integrated Media Technology Limited (<a class="mention" data-mention="$IMTE" data-symbol-id="IMTE" href="https://stocktwits.com/symbol/IMTE" target="_blank">$IMTE</a>)IMTE stock rose 5% pre-market on Wednesday, building on a 9.39% rise to close at $1.98 in the previous session.The uptick in share price comes after the company appointed Zhiyun Tan to its board of directors. Tan has over a decade of experience in business and tax advisory services. According to the tech company, Tan’s addition to the board will bolster its advisory capabilities.<figure class="image"><img style="aspect-ratio:1279/286;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_064506_eab9455f6b.png" alt="Screenshot 2024-10-30 064506.png" width="1279" height="286"><figcaption>IMTE's Sentiment and Message Volume on Oct 30 as of 6:45 a.m. ET | Source: Stocktwits</figcaption></figure>Stocktwits retail sentiment skyrocketed to ‘extremely bullish’ (97/100), its highest mark this year, as message volume hit a one-year peak at ‘extremely high’ (95/100).The stock has lost 23% of its value so far in 2024.GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)GlycoMimetics shares fell 16% pre-market Wednesday, following a massive 191% surge in the prior trading session, after announcing its acquisition of Crescent BioPharma, an oncology therapeutics developer focused on solid tumors.The merger has received approval from the boards of both companies, though closing remains contingent on stockholder approval and other customary conditions, with finalization expected by Q2 2025.Upon completion, GlycoMimetics plans to adopt Crescent Biopharma as its new name, marking a significant pivot in its strategic focus.<figure class="image"><img style="aspect-ratio:1280/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_065931_7a6c00f4c3.png" alt="Screenshot 2024-10-30 065931.png" width="1280" height="282"><figcaption>GlycoMimetics' Sentiment and Message Volume on Oct 30 as of 6:59 a.m. ET | Source: Stocktwits</figcaption></figure> Retail sentiment on Stocktwits has peaked for a second time this year to ‘extremely bullish’ (97/100) with ‘extremely high’ (97/100) message volume.GlycoMimetics’ stock has dipped 85% so far this year.Alphabet Inc. (<a class="mention" data-mention="$GOOG" data-symbol-id="GOOG" href="https://stocktwits.com/symbol/GOOG" target="_blank">$GOOG</a>)Shares of Google-parent Alphabet rose nearly 7% pre-market Wednesday, following a 1.2% gain in the prior session, after reporting strong quarterly earnings post-market close.Alphabet posted revenue of $88.27 billion, surpassing analysts’ expectations of $86.39 billion, and earnings of $2.12 per share, topping Wall Street’s forecast of $1.84 per share.The earnings report highlighted a historic milestone for Google-owned YouTube, which generated $50 billion in revenue for the first time.<figure class="image"><img style="aspect-ratio:1277/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_071149_0e8d6e2f5c.png" alt="Screenshot 2024-10-30 071149.png" width="1277" height="282"><figcaption>Alphabet's Sentiment and Message Volume on Oct 30 as of 7:11 a.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock remains in the ‘extremely bullish’ (92/100) territory with an uptick in chatter to ‘extremely high’ (87/100) amid the earnings buzz.Google’s stock has gained 31% so far in 2024.For updates and corrections email newsroom@stocktwits.com.Read more: <a href="https://stocktwits.com/news-articles/markets/equity/glw-stock-makes-retail-more-bullish-after-q3-earnings/cJ2DsSpRJw">Corning Stock Boosts Retail Bullishness As Wall Street Analysts Raise Price Targets Post Q3 Earnings</a> &nbsp;

Google is among the top 3 most bullish stocks on Stocktwits today

Alphabet, Integrated Media, GlycoMimetic: 3 Stocks Making Retail Most Bullish Pre-Market Today

Retail sentiment is bullish on all three stocks, driven by Google's impressive financial performance, GlycoMimetics' announcement of a merger and potential rebranding, and IMTE's recent board strengthening.

Integrated Media, GlycoMimetic, Alphabet: 3 Stocks Making Retail Most Bullish Pre-Market Today

GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GLYC_sentiment_and_message_volume_Oct_29_2d5d960690.png" alt="GLYC sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of GlycoMimetics surged over 200% on Tuesday, making it the top gainer across U.S. markets and reaching a near two-year high. The biotech firm’s rally follows news of its <a href="https://stocktwits.com/news-articles/markets/equity/glyc-stock-surges-on-acquisition-deal/cJ2uwL4RJq">acquisition agreement</a> with Crescent Biopharma, backed by a $200 million investment commitment from investors including Fairmount, Venrock Healthcare Capital, and BVF Partners.&nbsp;The combined company will operate under the Crescent Biopharma name. Retail sentiment on Stocktwits skyrocketed, shifting to “extremely bullish” (97/100) from “neutral” on Monday.Canaan Inc. ($CAN)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CAN_sentiment_and_message_volume_Oct_29_41df60828f.png" alt="CAN sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of Canaan Inc., a company focused on Bitcoin mining technology, surged nearly 20% to a three-month high on Tuesday as Bitcoin’s price reached a peak of $72,338 — its highest level since April.&nbsp;This Bitcoin surge fueled significant retail interest, causing Canaan’s Stocktwits sentiment score to jump to “extremely bullish” (97/100) from a previous “bearish” outlook.PayPal Holdings Inc. ($PYPL)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/PYPL_sentiment_and_message_volume_Oct_29_7f56a8c668.png" alt="PYPL sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Despite a 3% dip following its <a href="https://stocktwits.com/news-articles/markets/equity/paypal-stock-plummets-mixed-earnings-retail-investors-bullish/cJ2un8iRJm?source_caller=ui&amp;shortlink=sefos10f&amp;pid=ds&amp;af_click_lookback=7d&amp;af_xp=custom">Q3 earnings</a> report on Tuesday, which missed revenue expectations, PayPal saw a wave of retail optimism. The earnings report did exceed profit expectations, and management’s optimistic outlook reassured many investors, lifting Stocktwits sentiment to ‘extremely bullish’ (96/100).&nbsp;The divergence between sentiment and price suggests retail investors are focusing on PayPal’s long-term potential over short-term volatility.For updates and corrections, email&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/tmtg-core-civic-humana-stocks-poised-for-gains-with-trump-victory-retail-sentiment-mixed/cJ2urOCRJp">TMTG, CoreCivic, Humana Stocks Poised For Gains With Trump Victory: Retail Sentiment Mixed</a>

The most bullish stock during Tuesday's mid-day trading | Source: Pixabay

GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today

Acquisition news, Bitcoin ripping higher and management’s confident commentary despite a post-earnings dip are fueling a lot of optimism 

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

GLYC
GlycoMimetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLYC News

GLYC GlycoMimetics Inc